Shenglei Li

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy

Ling Yuan, Hui Yang, Kunlun Wang, 2021, Pathology & Oncology Research.

Local Ablative Treatment Improves Survival in ESCC Patients With Specific Metastases, 2010–2016: A Population-Based SEER Analysis

Ling Yuan, Kunlun Wang, Shenglei Li, 2022, Frontiers in Oncology.

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer

Ling Yuan, Hui Yang, Kunlun Wang, 2020, Frontiers in Oncology.

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma

Ling Yuan, Xiaotao Dong, Erjiang Zhao, 2022, Pathology & Oncology Research.

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy

Ling Yuan, Hui Yang, Kunlun Wang, 2021, Frontiers in Oncology.

The Safety and Efficacy of Camrelizumab and Its Combination With Apatinib in Various Solid Cancers

Ling Yuan, Hui Yang, Kunlun Wang, 2020, Frontiers in Pharmacology.